Search

Abstract:

Central venous catheters (CVC), used for the management of children with hemato-oncological disorders, are burdened by a significant incidence of mechanical, infective, or thrombotic complications. These complications favor an increasing risk in prolongation of hospitalization, extra costs of care, and sometimes severe life-threatening events. No guidelines for the management of CVC-related occlusion and CVC-related thrombosis are available for children.

[ctt tweet=”ReTweet if useful… Central venous catheter management in children http://ctt.ec/biIVf+ @ivteam #ivteam” coverup=”biIVf”]

To this aim, members of the coagulation defects working group and the supportive therapy working group of the Italian Association of Pediatric Hematology and Oncology (AIEOP) reviewed the pediatric and adult literature to propose the first recommendations for the management of CVC-related occlusion and CVC-related thrombosis in children with hemato-oncological disorders.

Reference:

Giordano, P., Saracco, P., Grassi, M., Luciani, M., Banov, L., Carraro, F., Crocoli, A., Cesaro, S., Zanazzo, G.A. and Molinari, A.C. (2015) Recommendations for the use of long-term central venous catheter (CVC) in children with hemato-oncological disorders: management of CVC-related occlusion and CVC-related thrombosis. On behalf of the coagulation defects working group and the supportive therapy working group of the Italian Association of Pediatric Hematology and Oncology (AIEOP).Annals of Hematology. August 25th. [epub ahead of print].

Thank you to our partners for supporting IVTEAM
[slideshow_deploy id=’23788’]